{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:44:58Z","timestamp":1767624298565,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.urology.2022.09.017","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T05:49:18Z","timestamp":1665553758000},"page":"117-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Improved Peyronie's Disease Curvature Outcomes Using a Novel Collagenase Administration Protocol"],"prefix":"10.1016","volume":"170","author":[{"given":"Ashley","family":"Flores","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissa","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klinton","family":"Brearton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevann","family":"Helo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Ziegelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6842-733X","authenticated-orcid":false,"given":"Landon","family":"Trost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2022.09.017_bib0001","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-5347(17)37988-0","article-title":"The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984","volume":"146","author":"Lindsay","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.017_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/282503","article-title":"A population-based study of peyronie's disease: prevalence and treatment patterns in the United States","volume":"2011","author":"Dibenedetti","year":"2011","journal-title":"Adv Urol"},{"key":"10.1016\/j.urology.2022.09.017_bib0003","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie's disease: results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2022.09.017_bib0004","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.ijir.3900727","article-title":"Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil","volume":"13","author":"Rhoden","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2022.09.017_bib0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1159\/000049830","article-title":"Peyronie's disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years","volume":"40","author":"La Pera","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.09.017_bib0006","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","article-title":"Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.017_bib0007","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.juro.2015.10.065","article-title":"Restoration of penile function and patient satisfaction with intralesional collagenase clostridium histolyticum injection for Peyronie's Disease","volume":"195","author":"Ziegelmann","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.017_bib0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bju.12634","article-title":"Minimally invasive treatment of Peyronie's disease: evidence-based progress","volume":"114","author":"Jordan","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2022.09.017_bib0009","article-title":"Treatment Patterns and Health Care Outcomes with Collagenase Clostridium Histolyticum vs Surgery in Peyronie's Disease: A Retrospective Claims Database Analysis","volume":"9","author":"Trost","year":"2021","journal-title":"Sex Med"},{"key":"10.1016\/j.urology.2022.09.017_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jsm.12731","article-title":"Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study","volume":"12","author":"Levine","year":"2015","journal-title":"J Sexual Med"},{"key":"10.1016\/j.urology.2022.09.017_bib0011","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.017_bib0012","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","article-title":"Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease","volume":"187","author":"Gelbard","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.017_bib0013","article-title":"Safety and Efficacy Study of Collagenase Clostridium Histolyticum Applied With an Intensive Protocol in the Treatment of Peyronie's Disease","volume":"9","author":"Melgarejo-Segura","year":"2021","journal-title":"Sex Med"},{"key":"10.1016\/j.urology.2022.09.017_bib0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.acuro.2020.06.016","article-title":"Efficacy and safety of collagenase Clostridium histolyticum in Peyronie's disease following a modified treatment protocol","volume":"45","author":"Garcia Cruz","year":"2021","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"10.1016\/j.urology.2022.09.017_bib0015","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41443-020-0286-9","article-title":"About the drawback of collagenase","volume":"33","author":"Garcia-Gomez","year":"2021","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2022.09.017_bib0016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.urology.2020.05.076","article-title":"Treatment-related Outcomes for Patients With Atypical Peyronie's Disease Using Xiaflex Injections","volume":"143","author":"El-Khatib","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.09.017_bib0017","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40261-020-00916-4","article-title":"Efficacy of Collagenase Clostridium histolyticum (Xiapex((R))) in Patients with the Acute Phase of Peyronie's Disease","volume":"40","author":"Cocci","year":"2020","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.urology.2022.09.017_bib0018","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2020.01.035","article-title":"The Influence of Indentation Deformity on Outcomes With Intralesional Collagenase Clostridium Histolyticum Monotherapy for Peyronie's Disease","volume":"139","author":"Ziegelmann","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.09.017_bib0019","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.urology.2017.01.054","article-title":"Clinical Experience With Penile Traction Therapy Among Men Undergoing Collagenase Clostridium histolyticum for Peyronie Disease","volume":"104","author":"Ziegelmann","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.09.017_bib0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.urology.2019.01.055","article-title":"Safety and Efficacy of Collagenase Clostridium Histolyticum in Peyronie's Disease Men With Ventral Curvatures","volume":"129","author":"Alom","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.09.017_bib0021","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jsxm.2019.03.007","article-title":"Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease","volume":"16","author":"Alom","year":"2019","journal-title":"J Sexual Med"},{"key":"10.1016\/j.urology.2022.09.017_bib0022","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jsxm.2018.08.012","article-title":"Sildenafil 25 mg ODT\u00a0+\u00a0Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis","volume":"15","author":"Cocci","year":"2018","journal-title":"J Sexual Med"},{"key":"10.1016\/j.urology.2022.09.017_bib0023","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41443-020-00383-7","article-title":"Conservative management of suspected fractures in men undergoing collagenase clostridium histolyticum for Peyronie's Disease is not associated with worsening of erectile function","volume":"34","author":"Sharma","year":"2022","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2022.09.017_bib0024","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.urology.2017.04.045","article-title":"Self-reported Clinical Meaningfulness Early in the Treatment Course Predicts Objective Outcomes in Men Undergoing Collagenase Clostridium histolyticum Injections for Peyronie Disease","volume":"106","author":"Ziegelmann","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.09.017_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41443-020-00383-7","article-title":"Conservative management of suspected fractures in men undergoing collagenase clostridium histolyticum for Peyronie\u2019s Disease is not associated with worsening of erectile function","volume":"34","author":"Sharma","year":"2022","journal-title":"Int J Impot Res"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522008305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522008305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:50:59Z","timestamp":1758768659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429522008305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":25,"alternative-id":["S0090429522008305"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2022.09.017","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved Peyronie's Disease Curvature Outcomes Using a Novel Collagenase Administration Protocol","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2022.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}